| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.5M | -39.0% |
| Cost of Revenue | $6.0M | -27.5% |
| Gross Profit | $3.5M | -52.1% |
| R&D Expense | $3.6M | +53.3% |
| SG&A Expense | $7.9M | +4.6% |
| Operating Income | -$8.4M | -227.1% |
| Pre-tax Income | -$11.2M | -359.9% |
| Income Tax | $15K | -37.5% |
| Net Income | -$11.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.3M | +187.2% |
| Accounts Receivable | $1.3M | -50.6% |
| Inventory | $7.6M | +16.1% |
| Current Assets | $28.3M | +65.2% |
| Total Assets | $43.2M | +37.6% |
| Current Liabilities | $1.5M | +2.4% |
| Total Liabilities | $5.7M | +21.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | -52.6% |
| Capital Expenditures | $43K | -95.6% |
| Investing Cash Flow | -$3.3M | -353.5% |
| Financing Cash Flow | $21.2M | +994.5% |
| Free Cash Flow | -$5.3M | -20.1% |
| -356.0% |
| EPS (Basic) | -$1.08 | -315.4% |
| EPS (Diluted) | -$1.08 | -315.4% |
| Stockholders' Equity |
| $37.5M |
| +40.5% |